CH Biotech R&D Co., Ltd. (TPE:6534)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
91.50
-0.30 (-0.33%)
Jun 25, 2026, 1:30 PM CST
Market Cap9.41B +16.1%
Revenue (ttm)1.84B +10.2%
Net Income491.30M +7.6%
EPS4.77 +8.1%
Shares Out 102.80M
PE Ratio19.18
Forward PEn/a
Dividend4.80 (5.23%)
Ex-Dividend DateMar 26, 2026
Volume25,137
Open91.80
Previous Close91.80
Day's Range91.20 - 92.10
52-Week Range76.50 - 123.50
Beta0.14
Analystsn/a
Price Targetn/a
Earnings DateAug 12, 2026

About CH Biotech R&D

CH Biotech R&D Co., Ltd., together with its subsidiaries, engages in the research, development, production, and sale of agriculture chemicals in Taiwan, the United States, and internationally. It offers fertilizers, biostimulants, and plant growth regulators; and provides biotechnology services. The company was incorporated in 2013 and is headquartered in Nantou City, Taiwan. [Read more]

Sector Materials
Founded 2013
Country Taiwan
Stock Exchange Taiwan Stock Exchange
Ticker Symbol 6534
Full Company Profile

Financial Performance

In 2025, CH Biotech R&D's revenue was 1.82 billion, an increase of 11.21% compared to the previous year's 1.64 billion. Earnings were 464.00 million, a decrease of -2.60%.

Financial Statements